DENEX Renal Denervation Therapy in Patients With Hypertension on no or 1-3 Antihypertensive Medications

  • End date
    Jan 31, 2023
  • participants needed
  • sponsor
    Handok Kalos Medical
Updated on 2 September 2021
systolic blood pressure
beta blockers
beta blocker
antihypertensive drugs
blood pressure diastolic


The objective of this study is to show that the safety and efficacy of renal denervation using DENEX, are superior to those of control group for the patients with hypertension on no or 1 to 3 antihypertensive medications.


DENEX system developed by Handok Kalos Medical Inc. is a renal denervation system to efficiently block the sympathetic nerve of the kidney with minimal invasive procedure. It was developed to block the sympathetic nerves distributed in blood vessel wall by delivering high frequency energy to the renal artery for the purpose of treating hypertension.

Condition Vascular Diseases, Hypertension, Cardiovascular Disease, Diabetes and Hypertension, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric), Elevated Blood Pressure, vascular disorder, high blood pressure, arterial hypertension, cardiovascular diseases, cardiovascular disease (cvd), cardiovascular system diseases, cardiovascular disorders, vascular disease, vasculopathy, vasc
Treatment Renal denervation
Clinical Study IdentifierNCT04307836
SponsorHandok Kalos Medical
Last Modified on2 September 2021


Yes No Not Sure

Inclusion Criteria

Subject aged 19 to 75 years old
Subject should maintain the 0 to 3 antihypertensive medications of different classes, ACE-I, ARB, beta blocker, CCB or diuretics, without change for at least 4 weeks of run-in period between primary screening and secondary screening and for at least 3 months after the procedure
Subject with 140 mmHg average office SBP < 180 mmHg and 90 mmHg office DBP < 120 mmHg at primary and secondary screening
Subject with 135 mmHg average daytime ambulatory SBP <170 mmHg and 85 mmHg average daytime ambulatory DBP < 105 mmHg at secondary screening after the run-in period for at least 4 weeks

Exclusion Criteria

Subject with the anatomical findings in kidney or renal artery which preclude renal denervation
Subject with type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus
Subject with eGFR less than 40mL/min/1.73
Subject with a brachial circumference greater than 42 cm
Subject with secondary hypertension (except for sleep apnea patients)
Subject with a medical history of cerebrovascular disease or severe cardiovascular disease within 12 months prior to obtaining the consent or patients newly diagnosed with such diseases before enrollment
Subject rehospitalized two or more times for hypertensive crisis within 12 months prior to obtaining consent or hospitalized for hypertensive crisis within three months prior to obtaining consent
Subject with chronic oxygen therapy or mechanical ventilation (except for sleep apnea)
Subject with primary pulmonary hypertension
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note